Subscribe To
Phathom pharmaceuticals presents new data at digestive disease week® (ddw) 2023
Higher H. pylori eradication rates demonstrated with vonoprazan-based regimens vs. lansoprazole triple therapy, regardless of different baseline demog...
May 9, 2023, 12:00 pm
Verrica pharmaceuticals reports first quarter 2023 financial results
New Drug Application for YCANTH™ (VP-102) PDUFA Goal Date of July 23, 2023 – Potential to Become Only FDA-approved Therapy for Treatment of Mollus...
May 9, 2023, 11:30 am
Arbutus to present at jmp securities life sciences conference
WARMINSTER, Pa., May 09, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage...
May 9, 2023, 11:30 am
Wall street analysts predict a 42.46% upside in agios pharmaceuticals (agio): here's what you should know
The consensus price target hints at a 42.5% upside potential for Agios pharmaceuticals (AGIO). While em...
May 9, 2023, 11:27 am
Atossa therapeutics to present insights from ongoing evangeline clinical trial at asco annual meeting
Atossa Therapeutics, Inc has announced that it will present a Trial in Progress poster for the Phase 2 clinical study of (Z)-endoxifen in premenopausa...
May 9, 2023, 10:23 am
Spectrum pharmaceuticals (sppi) reports q1 loss, tops revenue estimates
Spectrum pharmaceuticals (SPPI) came out with a quarterly loss of $0.02 per share versus the Zacks Cons...
May 9, 2023, 9:56 am
Tscan therapeutics stock soars after amgen collaboration on crohn's disease treatment that could bring in more than $500 million
Shares of TScan Therapeutics Inc. TCRX powered up 43.1% in premarket trading Tuesday, after the biopharmaceuti...
May 9, 2023, 9:15 am
Commodity chemicals market to witness growth at a 6.60% cagr – report by market research future (mrfr)
Commodity Chemicals Market Research Report Information By Product (Ester, Ether, Amine, Alcohol, Ketones, Fatty Chemicals, Chelating Agents and Others...
May 9, 2023, 8:47 am
Fusion pharmaceuticals to present at the guggenheim healthcare talks radiopharmaceuticals day
HAMILTON, ON and BOSTON , May 9, 2023 /PRNewswire/ -- Fusion pharmaceuticals Inc. (Nasdaq: FUSN), a cl...
May 9, 2023, 7:45 am
Ionis to present at upcoming investor conferences
CARLSBAD, Calif. , May 9, 2023 /PRNewswire/ -- Ionis pharmaceuticals, Inc. (Nasdaq: IONS) today announc...
May 9, 2023, 7:05 am
Nextcure to present at the jmp securities life sciences conference
BELTSVILLE, Md., May 09, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceu...
May 9, 2023, 7:00 am
Syndax pharmaceuticals, inc. (sndx) q1 2023 earnings call transcript
Syndax pharmaceuticals, Inc. (NASDAQ:SNDX ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Com...
May 8, 2023, 10:53 pm
Quoin pharmaceuticals provides corporate update and announces first quarter 2023 financial results
First patient dosed in Quoin’s single arm, open label clinical trial in Netherton Syndrome patients currently receiving off-label systemic therapy R...
May 8, 2023, 9:00 pm
Atea pharmaceuticals, inc. (avir) q1 2023 earnings call transcript
Atea pharmaceuticals, Inc. (NASDAQ:AVIR ) Q1 2023 Results Conference Call May 8, 2023 4:30 PM ET Compan...
May 8, 2023, 8:51 pm
Acadia pharmaceuticals inc. (acad) q1 2023 earnings call transcript
ACADIA pharmaceuticals Inc. (NASDAQ:ACAD ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Comp...
May 8, 2023, 8:03 pm
Enanta pharmaceuticals (enta) reports q2 loss, misses revenue estimates
Enanta pharmaceuticals (ENTA) came out with a quarterly loss of $1.79 per share versus the Zacks Consen...
May 8, 2023, 7:03 pm
Acadia pharmaceuticals (acad) reports q1 loss, lags revenue estimates
Acadia pharmaceuticals (ACAD) came out with a quarterly loss of $0.27 per share versus the Zacks Consen...
May 8, 2023, 7:02 pm
Johnson & johnson (jnj) shares are entering in a bull trap
Johnson & Johnson (JNJ) is an American multinational corporation founded in 1886 that develops medical devices, ...
May 8, 2023, 5:32 pm
Carisma therapeutics to present at the jmp securities life sciences conference
PHILADELPHIA , May 8, 2023 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage bio...
May 8, 2023, 4:30 pm
Ligand (lgnd) up 3% on raised '23 view, beats on q1 earnings
Ligand pharmaceuticals (LGND) announces better-than-expected results in first-quarter 2023. Management ...
May 8, 2023, 1:43 pm